Endologix Inc. to Present at the Canaccord Genuity 33rd Annual Growth Conference
8/2/2013 9:18:36 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
IRVINE, Calif., Aug. 1, 2013 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that Shelley Thunen, Chief Financial Officer, is scheduled to present at the Canaccord Genuity 33rd Annual Growth Conference in Boston, MA.
Help employers find you! Check out all the jobs and post your resume.
comments powered by